COVID-19与VISION 2020未竟议程
该视角文章结合全球视觉数据库(2017)与全球疾病负担研究(2017)数据,回顾1990年以来全球盲与视力损害的时间趋势,并评述COVID-19大流行可能对全球眼科与VISION 2020目标造成的冲击。文章指出,尽管各区域年龄标化中重度视力损害(MSVI)患病率普遍下降,但到2050年仍预计有超过7亿人面临MSVI或盲,COVID-19威胁全球眼科已取得的成果。
要点
- 1990至2017年各区域年龄标化MSVI患病率普遍下降,VISION 2020取得成效。
- 1990至2017年低收入国家维生素A缺乏、未矫正屈光不正、白内障等年龄标化患病率均下降。
- 粗略预测到2050年超过7亿人将患MSVI或盲,主要因全球人口增长与老龄化。
核心结论
- 尽管VISION 2020取得诸多显著成功,全球盲与视力损害负担在未来数年仍将达历史水平。
- COVID-19影响尚未完全确定,但正威胁全球眼科来之不易的成果。
- 后疫情年代需要 renewed effort,聚焦视力倡导与全球眼保健服务扩展。
研究设计与样本
- 视角文章(Perspective),辅以可用在线数据库的流行病学数据。
- 数据提取自全球视觉数据库(2017)与全球疾病负担研究(2017)。
主要发现
- 自1990年以来,所有世界区域年龄标化MSVI合并患病率普遍下降。
- 1990至2017年低收入国家每10万人年龄标化患病率:维生素A缺乏由25,155降至19,187。
- 同期未矫正屈光不正由2,286降至2,040,白内障由1,846降至1,690。
- 同期盘尾丝虫病由5,577降至2,871,沙眼由506降至159,麻风由36降至26。
- 粗略预测到2050年超过7亿人将患MSVI或盲,主要因全球人口增长与老龄化。
临床怎么用
- 后疫情年代应重新投入视力倡导并扩大全球眼保健服务覆盖。
- 关注人口增长与老龄化驱动的盲与视力损害负担上升趋势。
局限性
- COVID-19对全球眼科的影响尚未完全确定。
- 2050年预测为粗略预测(crude projections)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To critically evaluate the potential impact of the coronavirus disease (COVID-19) pandemic on global ophthalmology and VISION 2020. DESIGN: Perspective supplemented with epidemiologic insights from available online databases. METHODS: We extracted data from the Global Vision Database (2017) and Global Burden of Disease Study (2017) to highlight temporal trends in global blindness since 1990, and provide a narrative overview of how COVID-19 may derail progress toward the goals of VISION 2020. RESULTS: Over 2 decades of VISION 2020 advocacy and program implementation have culminated in a universal reduction of combined age-standardized prevalence of moderate-to-severe vision impairment (MSVI) across all world regions since 1990. Between 1990 and 2017, low-income countries observed large reductions in the age-standardized prevalence per 100,000 persons of vitamin A deficiency (25,155 to 19,187), undercorrected refractive disorders (2,286 to 2,040), cataract (1,846 to 1,690), onchocerciasis (5,577 to 2,871), trachoma (506 to 159), and leprosy (36 to 26). Despite these reductions, crude projections suggest that more than 700 million persons will experience MSVI or blindness by 2050, principally owing to our growing and ageing global population. CONCLUSIONS: Despite the many resounding successes of VISION 2020, the burden of global blindness and vision impairment is set to reach historic levels in the coming years. The impact of COVID-19, while yet to be fully determined, now threatens the hard-fought gains of global ophthalmology. The postpandemic years will require renewed effort and focus on vision advocacy and expanding eye care services worldwide.
引用
- Ung L, Jonas JB, Lietman TM, et al. COVID-19 and the Unfinished Agenda of VISION 2020. Am J Ophthalmol. 2020. PMID: 33309690. doi:10.1016/j.ajo.2020.11.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。